Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Different diagnostic methods for breast cancer compared
August 25th, 2005
Different diagnostic methods for breast cancer were compared. "Determination of Her-2/neu overexpression in breast cancer has previously been shown to be of prognostic significance. In this study, Her-2/neu expression in breast cancer was characterized by real-time PCR (RLT-PCR) based LightCycler-HER-2/neu DNA quantification with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Fifteen specimens of invasive breast cancer (whole tissue sections as well as micro-dissected tumor cells) were subjected to RLT-PCR," researchers in Germany reported. "Additionally, IHC and FISH were performed. Her-2/neu overexpression was detected by...
Source: Women's Health Weekly (2005-08-25)
|
